However, treatment with PRIMA-1Met or SAS alone, and even more so their combination, caused a decrease in total glutathione levels (GSH + GSSG), which was more pronounced in CLL cells with mutant p53 compared to those expressing the wt protein (Figure 10B). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.